AMP vigilance
Published on 26 March 2025
MPA Vigilance is a mission of the Agence de la biomédecine, which involves monitoring the risks associated with the entire process, from the collection to the use of gametes and embryos for therapeutic purposes, as part of medically assisted procreation activities, and reporting any undesirable events that may occur during these activities. Here you will find regulatory texts, newsletters, application access forms, guides and guidelines, annual reports and declaration forms concerning MPA Vigilance and risk mapping.
Contact AMP Vigilance representatives: ampvigilance@biomedecine.fr